0001485003-16-000174.txt : 20160922
0001485003-16-000174.hdr.sgml : 20160922
20160922165404
ACCESSION NUMBER: 0001485003-16-000174
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160920
FILED AS OF DATE: 20160922
DATE AS OF CHANGE: 20160922
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 252025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-9911
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HURLY STEPHEN A
CENTRAL INDEX KEY: 0001130637
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 161898052
MAIL ADDRESS:
STREET 1: C/O ELEVEN BIOTHERAPEUTICS
STREET 2: 215 FIRST ST. #400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
wf-form4_147457763133880.xml
FORM 4
X0306
4
2016-09-20
0
0001485003
Eleven Biotherapeutics, Inc.
EBIO
0001130637
HURLY STEPHEN A
C/O ELEVEN BIOTHERAPEUTICS, INC.
215 FIRST STREET, SUITE 400
CAMBRIDGE
MA
02142
1
1
0
0
President and CEO
Common Stock
2016-09-20
4
A
0
398031
A
398031
D
Stock Option
3.37
2016-09-20
4
A
0
350000
0
A
2026-09-19
Common Stock
350000.0
350000
D
The reporting person acquired 398,031 shares of issuer common stock in exchange for a 9.9175% interest in Viventia Bio Inc. pursuant to the issuer's purchase of all of the outstanding capital stock of Viventia Bio Inc. on September 20, 2016. Of the 398,031 shares issued to the reporting person in the transaction, 39,803 shares are currently being held in escrow and are subject to forfeiture during the 15-month period following the transaction to satisfy claims arising as a result of Viventia Bio Inc.'s or the reporting person's breach of any of its or his representations, warranties or covenants in the share purchase agreement.
25% of the shares subject to such option shall vest on the first anniversary of the date of grant of the option and an additional 6.25% of the shares underlying the option shall vest at the end of each successive three-month period thereafter until the fourth anniversary of the date of grant of the option.
/s/ Stephen A. Hurly
2016-09-22